首页> 美国卫生研究院文献>Canadian Medical Association Journal >The authors reply to: Doubts about first report of krokodil use in Canada
【2h】

The authors reply to: Doubts about first report of krokodil use in Canada

机译:作者回答:有关在加拿大首次使用克罗考定的报道的疑问

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We agree with Dr. Mitchell’s comment on our case report that critique is a part of the scientific process. To elaborate on our brief report, the patient was referred to the academic dermatology service for a presumptive diagnosis of pyoderma gangrenosum. Despite the clinical presentation of the ulcers not being classic for pyoderma gangrenosum, the patient was treated aggressively for this condition in hospital with high-dose steroids for more than a month, antibiotics, and increasing doses of cyclosporine as a steroid-sparing agent, as well as intensive wound care. No substantial improvement occurred in this patient with this aggressive treatment, and the small improvements that were seen were most likely due to secondary infection responding to the antibiotics. The disease course was clearly not typical of pyoderma gangrenosum as a decreased ulcer size within 1 month of starting immunosuppressive medications was expected (a diagnostic criterion of pyoderma gangrenosum).
机译:我们同意米切尔(Mitchell)博士对我们的病例报告的评论,即批评是科学过程的一部分。为了详细介绍我们的简要报告,该患者被转诊至皮肤科学术机构以对坏疽性脓皮病进行推定诊断。尽管临床表现溃疡不是坏疽性脓皮病的典型表现,但在医院中积极治疗此病的患者接受了一个多月的大剂量类固醇,抗生素和增加剂量的环孢素作为类固醇保护剂,以及深入的伤口护理。接受这种积极治疗后,该患者的病情没有实质性改善,所见的微小改善最有可能是由于对抗生素的继发感染所致。由于预期在开始免疫抑制药物后1个月内溃疡大小会减少(坏疽性脓皮病的诊断标准),因此该病程显然不是坏疽性脓皮病的典型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号